Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis

JID Innovations(2024)10.1016/j.xjidi.2024.100261Source: DataRank Database

Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis is a research paper published in JID Innovations (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 5.17)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Sherif A. Eldirany ORCID,Giovanni Damiani ORCID,Minh Ho ORCID,Christopher G. Bunick ORCID,Stefano G. Daniele ORCID

Live enrichment

PubMed:38445231 PMC:PMC10914523 OpenAlex:https://openalex.org/W4391042843

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: R01 AR079428

National Institute of General Medical Sciences

Grant: T32GM007205

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 5T32GM007205-23

MEDICAL SCIENTIST TRAINING PROGRAM

National Institutes of Health

Grant: 5R01AR079428-03

Molecular function of an intermediate filament assembly mechanism in epidermal protein complexes and cell migration

National Institutes of Health

Yale University

FWCI

5.17

Citation Percentile

1.0%

Influential Citations

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.jidinnovations.org/article/S2667026724000079/pdf

GOLDhttp://www.jidinnovations.org/article/S2667026724000079/pdf

publisherhttp://www.jidinnovations.org/article/S2667026724000079/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2667026724000079?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2667026724000079?httpAccept=text/plain

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchCytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisMedicine03 medical and health sciences0302 clinical medicine

Keywords

EpitopePsoriasisEpitope mappingInterleukin 23Conformational epitopeChemistryMedicineImmunologyPharmacologyInterleukin 17AntibodyInflammationUstekinumabGuselkumabTildrakizumabRisankizumabInflammatory Skin Disease EpitopeOriginal ArticleGuselkumab; Inflammatory skin disease epitope; Risankizumab; Tildrakizumab; Ustekinumab

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (1)

A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

N/A

3.0DataRank · unranked

Journal of Investigative Dermatology(2020)

co-cited

10.1016/j.jid.2020.01.025

Structural Basis for p19 Targeting by Anti–IL-23 Biologics: Correlations with Short- and Long-Term Efficacy in Psoriasis

FAIR Checklist

Authors (5)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (1)